Evidence map›Paper›PMID 39575134›Full record

ArticleJournal of health economics and outcomes research2024

Retrospective Analysis of RSV Infection in Pediatric Patients: Epidemiology, Comorbidities, Treatment, and Costs in Dubai (2014-2023).

Jean Joury, Nawal Al Kaabi, Sara Al Dallal, Bassam Mahboub, Mostafa Zayed, Mohamed Abdelaziz, Jennifer Onwumeh-Okwundu, Mark A Fletcher, Subramanyam Kumaresan, Badarinath C Ramachandrachar and 1 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of health economics and outcomes research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07015255 (Assessing the Burden of Respiratory Syncytial Virus), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07015255 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Assessing the Burden of Respiratory Syncytial Virus (RSV): the Assessment of the Burden of Respiratory Syncytial Virus (RSV) Across Different Age Groups and Risk Factors

TypeobservationalSponsorAbu Dhabi Health Services CompanyRan2025 to 2026Enrolled1,500ConditionsRespiratory Syncytial Virus (RSV) Infection, Acute Lower Respiratory Tract Infections, Bronchiolitis, Pneumonia
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jean JouryPfizer Gulf FZ LLC, Dubai, UAE.
Nawal Al KaabiCollege of Medicine and Health Science, Khalifa University, Abu Dhabi, UAE.
Sara Al DallalDubai Health Authority, Dubai, UAE.
Bassam MahboubDubai Health Authority, Dubai, UAE.
Mostafa ZayedPfizer Gulf FZ LLC, Dubai, UAE.
Mohamed AbdelazizPfizer Gulf FZ LLC, Dubai, UAE.
Jennifer Onwumeh-OkwunduPfizer Inc., Memphis, Tennessee, USA.
Mark A FletcherPfizer Inc., Paris, France.
Subramanyam KumaresanEMEA Consulting Services, IQVIA, Bengaluru, India.
Badarinath C RamachandracharReal-World Evidence, IQVIA, Dubai, UUAE.
Mohamed FarghalyHealth Economics & Insurance Policies Department Dubai Health Authority, Dubai, UAE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

e-claims databasehospitalizationimmunoprophylaxisinfantslower respiratory tract infectionpalivizumabrespiratory syncytial virus

Identifiers

PMID39575134
PMCPMC11580195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.